Logo image of USAC

USA COMPRESSION PARTNERS LP (USAC) Stock Fundamental Analysis

NYSE:USAC - US90290N1090

24.06 USD
-0.09 (-0.37%)
Last: 8/29/2025, 8:04:00 PM
24.06 USD
0 (0%)
After Hours: 8/29/2025, 8:04:00 PM
Fundamental Rating

4

USAC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 61 industry peers in the Energy Equipment & Services industry. USAC has a medium profitability rating, but doesn't score so well on its financial health evaluation. USAC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year USAC was profitable.
USAC had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: USAC reported negative net income in multiple years.
USAC had a positive operating cash flow in each of the past 5 years.
USAC Yearly Net Income VS EBIT VS OCF VS FCFUSAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

USAC has a Return On Assets of 2.95%. This is comparable to the rest of the industry: USAC outperforms 47.54% of its industry peers.
USAC has a Return On Invested Capital of 9.84%. This is in the better half of the industry: USAC outperforms 77.05% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for USAC is in line with the industry average of 8.01%.
The last Return On Invested Capital (9.84%) for USAC is above the 3 year average (7.42%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.95%
ROE N/A
ROIC 9.84%
ROA(3y)1.02%
ROA(5y)-4.03%
ROE(3y)100.53%
ROE(5y)43.2%
ROIC(3y)7.42%
ROIC(5y)6.26%
USAC Yearly ROA, ROE, ROICUSAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

USAC has a better Profit Margin (8.02%) than 67.21% of its industry peers.
Looking at the Operating Margin, with a value of 31.47%, USAC belongs to the top of the industry, outperforming 95.08% of the companies in the same industry.
In the last couple of years the Operating Margin of USAC has grown nicely.
USAC's Gross Margin of 66.61% is amongst the best of the industry. USAC outperforms 98.36% of its industry peers.
In the last couple of years the Gross Margin of USAC has remained more or less at the same level.
Industry RankSector Rank
OM 31.47%
PM (TTM) 8.02%
GM 66.61%
OM growth 3Y11.7%
OM growth 5Y4.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.12%
GM growth 5Y-0.08%
USAC Yearly Profit, Operating, Gross MarginsUSAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

USAC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
USAC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for USAC has been increased compared to 5 years ago.
Compared to 1 year ago, USAC has a worse debt to assets ratio.
USAC Yearly Shares OutstandingUSAC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
USAC Yearly Total Debt VS Total AssetsUSAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of USAC is 9.69, which is on the high side as it means it would take USAC, 9.69 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 9.69, USAC perfoms like the industry average, outperforming 44.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.69
Altman-Z N/A
ROIC/WACC1.17
WACC8.43%
USAC Yearly LT Debt VS Equity VS FCFUSAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

USAC has a Current Ratio of 1.27. This is a normal value and indicates that USAC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.27, USAC is doing worse than 77.05% of the companies in the same industry.
A Quick Ratio of 0.57 indicates that USAC may have some problems paying its short term obligations.
The Quick ratio of USAC (0.57) is worse than 96.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.57
USAC Yearly Current Assets VS Current LiabilitesUSAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

USAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.54%, which is quite good.
The Revenue has grown by 8.21% in the past year. This is quite good.
Measured over the past years, USAC shows a small growth in Revenue. The Revenue has been growing by 6.36% on average per year.
EPS 1Y (TTM)17.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.35%
Revenue 1Y (TTM)8.21%
Revenue growth 3Y14.53%
Revenue growth 5Y6.36%
Sales Q2Q%6.29%

3.2 Future

The Earnings Per Share is expected to grow by 28.83% on average over the next years. This is a very strong growth
USAC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.15% yearly.
EPS Next Y6.86%
EPS Next 2Y24.43%
EPS Next 3Y28.83%
EPS Next 5YN/A
Revenue Next Year14.47%
Revenue Next 2Y9.43%
Revenue Next 3Y8.15%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USAC Yearly Revenue VS EstimatesUSAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
USAC Yearly EPS VS EstimatesUSAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.91, which means the current valuation is very expensive for USAC.
Based on the Price/Earnings ratio, USAC is valued a bit more expensive than 62.30% of the companies in the same industry.
When comparing the Price/Earnings ratio of USAC to the average of the S&P500 Index (27.08), we can say USAC is valued slightly more expensively.
A Price/Forward Earnings ratio of 20.18 indicates a rather expensive valuation of USAC.
USAC's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. USAC is more expensive than 67.21% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.72, USAC is valued at the same level.
Industry RankSector Rank
PE 35.91
Fwd PE 20.18
USAC Price Earnings VS Forward Price EarningsUSAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, USAC is valued a bit more expensive than 77.05% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, USAC is valued a bit cheaper than 62.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.43
EV/EBITDA 9.31
USAC Per share dataUSAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of USAC may justify a higher PE ratio.
A more expensive valuation may be justified as USAC's earnings are expected to grow with 28.83% in the coming years.
PEG (NY)5.24
PEG (5Y)N/A
EPS Next 2Y24.43%
EPS Next 3Y28.83%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.70%, USAC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.38, USAC pays a better dividend. On top of this USAC pays more dividend than 98.36% of the companies listed in the same industry.
USAC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 8.7%

5.2 History

The dividend of USAC decreases each year by -0.70%.
USAC has paid a dividend for at least 10 years, which is a reliable track record.
USAC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.7%
Div Incr Years0
Div Non Decr Years11
USAC Yearly Dividends per shareUSAC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

338.25% of the earnings are spent on dividend by USAC. This is not a sustainable payout ratio.
DP338.25%
EPS Next 2Y24.43%
EPS Next 3Y28.83%
USAC Yearly Income VS Free CF VS DividendUSAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M
USAC Dividend Payout.USAC Dividend Payout, showing the Payout Ratio.USAC Dividend Payout.PayoutRetained Earnings

USA COMPRESSION PARTNERS LP

NYSE:USAC (8/29/2025, 8:04:00 PM)

After market: 24.06 0 (0%)

24.06

-0.09 (-0.37%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners39.12%
Inst Owner Change5.8%
Ins Owners0.47%
Ins Owner Change0.07%
Market Cap2.95B
Analysts50.91
Price Target27.13 (12.76%)
Short Float %4.29%
Short Ratio14.23
Dividend
Industry RankSector Rank
Dividend Yield 8.7%
Yearly Dividend2.43
Dividend Growth(5Y)-0.7%
DP338.25%
Div Incr Years0
Div Non Decr Years11
Ex-Date07-28 2025-07-28 (0.525)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.87%
Min EPS beat(2)-38.94%
Max EPS beat(2)5.21%
EPS beat(4)1
Avg EPS beat(4)-24.54%
Min EPS beat(4)-38.94%
Max EPS beat(4)5.21%
EPS beat(8)4
Avg EPS beat(8)-9.94%
EPS beat(12)4
Avg EPS beat(12)-74.62%
EPS beat(16)5
Avg EPS beat(16)-58.26%
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-1.8%
Max Revenue beat(2)-0.62%
Revenue beat(4)0
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)-0.62%
Revenue beat(8)1
Avg Revenue beat(8)-1.07%
Revenue beat(12)3
Avg Revenue beat(12)-0.67%
Revenue beat(16)3
Avg Revenue beat(16)-0.81%
PT rev (1m)-1.48%
PT rev (3m)-2.21%
EPS NQ rev (1m)2.33%
EPS NQ rev (3m)-22.45%
EPS NY rev (1m)3.09%
EPS NY rev (3m)-15.39%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 35.91
Fwd PE 20.18
P/S 3.01
P/FCF 11.43
P/OCF 8.25
P/B N/A
P/tB N/A
EV/EBITDA 9.31
EPS(TTM)0.67
EY2.78%
EPS(NY)1.19
Fwd EY4.95%
FCF(TTM)2.11
FCFY8.75%
OCF(TTM)2.91
OCFY12.11%
SpS8
BVpS-0.39
TBVpS-2.03
PEG (NY)5.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.95%
ROE N/A
ROCE 12.46%
ROIC 9.84%
ROICexc 9.84%
ROICexgc 10.71%
OM 31.47%
PM (TTM) 8.02%
GM 66.61%
FCFM 26.33%
ROA(3y)1.02%
ROA(5y)-4.03%
ROE(3y)100.53%
ROE(5y)43.2%
ROIC(3y)7.42%
ROIC(5y)6.26%
ROICexc(3y)7.42%
ROICexc(5y)6.26%
ROICexgc(3y)8.2%
ROICexgc(5y)6.97%
ROCE(3y)9.4%
ROCE(5y)7.92%
ROICexcg growth 3Y26.79%
ROICexcg growth 5Y13.4%
ROICexc growth 3Y28.36%
ROICexc growth 5Y18.89%
OM growth 3Y11.7%
OM growth 5Y4.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.12%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.69
Debt/EBITDA 4.27
Cap/Depr 35.77%
Cap/Sales 10.11%
Interest Coverage 250
Cash Conversion 61%
Profit Quality 328.16%
Current Ratio 1.27
Quick Ratio 0.57
Altman-Z N/A
F-Score6
WACC8.43%
ROIC/WACC1.17
Cap/Depr(3y)77%
Cap/Depr(5y)59.11%
Cap/Sales(3y)22.93%
Cap/Sales(5y)18.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.35%
EPS Next Y6.86%
EPS Next 2Y24.43%
EPS Next 3Y28.83%
EPS Next 5YN/A
Revenue 1Y (TTM)8.21%
Revenue growth 3Y14.53%
Revenue growth 5Y6.36%
Sales Q2Q%6.29%
Revenue Next Year14.47%
Revenue Next 2Y9.43%
Revenue Next 3Y8.15%
Revenue Next 5YN/A
EBIT growth 1Y12.44%
EBIT growth 3Y27.94%
EBIT growth 5Y11.38%
EBIT Next Year98.59%
EBIT Next 3Y29.12%
EBIT Next 5YN/A
FCF growth 1Y299.28%
FCF growth 3Y-14.74%
FCF growth 5Y1.06%
OCF growth 1Y36.74%
OCF growth 3Y8.75%
OCF growth 5Y2.57%